Literature DB >> 34074355

Changes in depression and suicidal ideation under severe lockdown restrictions during the first wave of the COVID-19 pandemic in Spain: a longitudinal study in the general population.

J L Ayuso-Mateos1,2,3, D Morillo1,2,3, J M Haro2,4, B Olaya2,4, E Lara1,2,3, M Miret1,2,3.   

Abstract

AIMS: To assess whether there is a change in the prevalence of depression and suicidal ideation after the strict lockdown measures due to the first wave of the COVID-19 pandemic in Spain; and to assess which are the factors associated with the incidence of a depressive episode or suicidal ideation during the lockdown.
METHODS: Data from a longitudinal adult population-based cohort from the provinces of Madrid and Barcelona were analysed (n = 1103). Structured face-to-face home-based interviews (pre-pandemic) and telephone interviews were performed. Both depression and suicidal ideation were assessed through an adaptation of the Composite International Diagnostic Interview (CIDI 3.0). A variety of validated instruments and sociodemographic variables including age, sex, educational level, occupational status, home quietness, screen time, resilience, loneliness, social support, physical activity, disability, economic situation and COVID-19-related information were also considered. Population prevalence estimates and multivariable logistic regressions were computed.
RESULTS: Overall, prevalence rates of depression and suicidal ideation did not change significantly from before to after the COVID-19 outbreak. However, the rates of depression among individuals aged 50+ years showed a significant decrease compared to before the pandemic (from 8.48 to 6.41%; p = 0.01). Younger individuals (odds ratio (OR) = 0.97 per year older; 95% confidence interval (CI) = 0.95-0.99) and those feeling loneliness (OR = 1.96; 95% CI = 1.42-2.70) during the lockdown were at an increased risk of developing depression during the confinement. Resilience showed a protective effect against the risk of depression (OR = 0.46; 95% CI = 0.32-0.66) and suicidal ideation (OR = 0.33; 95% CI = 0.16-0.68), whereas individuals perceiving social support were at a lower risk of developing suicidal thoughts (OR = 0.35; 95% CI = 0.18-0.69).
CONCLUSIONS: Continuous reinforcement of mental health preventive and intervening measures during and in the aftermath of the crisis is of global importance, particularly among vulnerable groups who are experiencing the most distress. Future research should strive to evaluate the long-term effects of the COVID-19 crisis on mental health.

Entities:  

Keywords:  Depression; population survey; risk factors; suicide

Year:  2021        PMID: 34074355     DOI: 10.1017/S2045796021000408

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  11 in total

1.  Trauma and stressor-related disorders among health care workers during COVID-19 pandemic and the role of the gender: A prospective longitudinal survey.

Authors:  Manuel Canal-Rivero; Laura Armesto-Luque; Ana Rubio-García; Gonzalo Rodriguez-Menéndez; Nathalia Garrido-Torres; Luis Capitán; Asunción Luque; Benedicto Crespo-Facorro; Miguel Ruiz-Veguilla
Journal:  J Affect Disord       Date:  2022-01-13       Impact factor: 4.839

Review 2.  Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review).

Authors:  Vasiliki Efstathiou; Maria-Ioanna Stefanou; Nikolaos Siafakas; Michael Makris; Georgios Tsivgoulis; Vassilios Zoumpourlis; Demetrios A Spandidos; Nikolaos Smyrnis; Emmanouil Rizos
Journal:  Exp Ther Med       Date:  2021-12-02       Impact factor: 2.447

3. 

Authors:  Javier-David Lopez-Morinigo; Hilario Blasco-Fontecilla; Philippe Courtet; José-Luis Ayuso-Mateos
Journal:  Rev Psiquiatr Salud Ment       Date:  2022-02-28       Impact factor: 6.795

4.  Socio-economic and psychological impact of COVID-19 pandemic in a Spanish cohort BIOVAL-D-COVID-19 study protocol.

Authors:  Andrea Miranda-Mendizabal; Silvia Recoder; Ester Calbo Sebastian; Marc Casajuana Closas; David Leiva Ureña; Rumen Manolov; Nuria Matilla Santander; Carlos G Forero; Pere Castellví
Journal:  Gac Sanit       Date:  2021-10-20       Impact factor: 2.139

5.  [Suicide mortality in Spain in 2020: The impact of the COVID-19 pandemic].

Authors:  Alejandro de la Torre-Luque; Andres Pemau; Victor Perez-Sola; Jose Luis Ayuso-Mateos
Journal:  Rev Psiquiatr Salud Ment       Date:  2022-02-02       Impact factor: 3.318

Review 6.  Mental Health Consequences of COVID-19 Pandemic Period in the European Population: An Institutional Challenge.

Authors:  Nicola Di Fazio; Donato Morena; Giuseppe Delogu; Gianpietro Volonnino; Federico Manetti; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

7.  Adolescent mobile phone addiction during the COVID-19 pandemic predicts subsequent suicide risk: a two-wave longitudinal study.

Authors:  Gangqin Li; Aldo Alberto Conti; Changjian Qiu; Wanjie Tang
Journal:  BMC Public Health       Date:  2022-08-12       Impact factor: 4.135

8.  Hospitalizations for Anorexia Nervosa during the COVID-19 Pandemic in France: A Nationwide Population-Based Study.

Authors:  Jean-Christophe Chauvet-Gelinier; Adrien Roussot; Bruno Vergès; Jean-Michel Petit; Fabrice Jollant; Catherine Quantin
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

9.  Resilience and Depressive Symptoms Mediated Pathways from Social Support to Suicidal Ideation Among Undergraduates During the COVID-19 Campus Lockdown in China.

Authors:  Xiaoning Zhang; Xin Liu; Yanyan Mi; Wei Wang; Haibo Xu
Journal:  Psychol Res Behav Manag       Date:  2022-08-23

10.  Changes in suicidal ideation and related influential factors in college students during the COVID-19 lockdown in China.

Authors:  Shuiqing Huang; Dongfang Wang; Jingbo Zhao; Huilin Chen; Zijuan Ma; Ye Pan; Xianchen Liu; Fang Fan
Journal:  Psychiatry Res       Date:  2022-05-28       Impact factor: 11.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.